Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
AKYA Akoya Biosciences
11.750-0.240-2.00%
Close
02/06 16:00 ET
11.7500.0000.00%
Post Mkt Price 02/06 16:01 ET
High
12.790
Open
11.910
Turnover
2.04M
Low
11.712
Pre Close
11.990
Volume
168.45K
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Akoya to Report Fourth Quarter and Full Year 2022 Financial Results on March 6th, 2023 and Participate at Two Upcoming Investor Conferences
MARLBOROUGH, Mass., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (NASDAQ:AKYA) ("Akoya"), The Spatial Biology Company®, today announced that it will release financial results for the fourth quarter
Akoya Biosciences (NASDAQ:AKYA) Coverage Initiated at UBS Group
Equities researchers at UBS Group assumed coverage on shares of Akoya Biosciences (NASDAQ:AKYA – Get Rating) in a research note issued on Thursday, The Fly reports. The brokerage set a "buy" rating a
Akoya Biosciences (NASDAQ:AKYA) Coverage Initiated by Analysts at UBS Group
UBS Group assumed coverage on shares of Akoya Biosciences (NASDAQ:AKYA – Get Rating) in a report published on Thursday, The Fly reports. The firm issued a buy rating and a $14.00 price target on the
Akoya Biosciences (NASDAQ:AKYA) Receives New Coverage From Analysts at UBS Group
Stock analysts at UBS Group initiated coverage on shares of Akoya Biosciences (NASDAQ:AKYA – Get Rating) in a note issued to investors on Thursday, The Fly reports. The brokerage set a "buy" rating o
UBS Initiates Coverage on Akoya Biosciences With Buy Rating, $14 Price Target
08:58 AM EST, 02/02/2023 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may co
Akoya Biosciences Initiated With a Buy at UBS
Akoya Biosciences to Present Results From Spatial Multiomics Study
Akoya Biosciences to Present First-of-its-Kind Spatial Multiomics Dataset at 2023 AGBT General Meeting
Simultaneous detection of proteins and RNA markers across 23 different tissue samples demonstrate robust and scalable capabilities of company's multiomics solutionMARLBOROUGH, Mass., Feb. 01, 2023 (
Short Interest in Akoya Biosciences, Inc. (NASDAQ:AKYA) Declines By 5.2%
Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Rating) was the target of a large decline in short interest during the month of January. As of January 15th, there was short interest totalling 571,500 shar
Global AI-based Digital Pathology/AI Pathology Market Research Report 2022-2035 Featuring Profiles of PathAI, Paige, Akoya Biosciences, PROSCIA, Visiopharm, Roche, Aiforia, Indica Labs, & Ibex
DUBLIN, Jan. 21, 2023 /PRNewswire/ -- The "AI-based Digital Pathology/AI Pathology Market Distribution by Type of Neural Network, Type of Assay, Type of End-user, Area of Application, Type of Target
Company Overview
More
Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. Akoya offers two distinct solutions, the CODEX and Phenoptics platforms, to serve the diverse needs of researchers across discovery, translational and clinical research. The company was founded by Garry Nolan, Yury Goltsev and Nikolay Samusik in 2015 and is headquartered in Marlborough, MA.
CEO： Mr. Brian McKelligon
Market： NASDAQ
Listing Date： 04/16/2021
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet